Condition: Hypertensive Disorders of Pregnancy · Preeclampsia · Gestational Hypertension · Sponsor: Ohio State University
The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.
This description comes directly from the study's public registry record.
Maged Costantine, MD, MBA · 614-293-2222 · Maged.Costantine@osumc.edu
Kara Rood, MD · 614-293-8045 · Kara.Rood@osumc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| University of Mississippi | Jackson, Mississippi, United States | Recruiting |
| University of New Mexico | Albuquerque, New Mexico, United States | Recruiting |
| Columbia University | New York, New York, United States | Recruiting |
| University of North Carolina, Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine | Columbus, Ohio, United States | Recruiting |
| University of Pittsburg Magee | Pittsburgh, Pennsylvania, United States | Recruiting |
| Brown University | Providence, Rhode Island, United States | Recruiting |
| University of Texas, Houston | Houston, Texas, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06468202